IS SYMPTOM ASSESSMENT OF VALUE IN LYMPHOMA SURVIVORS AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)?

被引:0
|
作者
Ionova, T. [1 ]
Fedorenko, D. [1 ]
Mochkin, N. [1 ]
Kurbatova, K. [2 ]
Gorodokin, G. [3 ]
Novik, A. [1 ]
机构
[1] Natl Pirogov Med Surg Ctr, Moscow, Russia
[2] Multinatl Ctr Qual Life Res, St Petersburg, Russia
[3] New Jersey Ctr Qual Life & Hlth Outcome Res, Saddle River, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B1674
引用
收藏
页码:656 / 656
页数:1
相关论文
共 50 条
  • [1] Quality of life in lymphoma survivors after autologous haematopoietic stem cell transplantation (AHSCT)
    Fedorenko, D. A.
    Mochkin, N. E.
    Kurbatova, K. A.
    Melnichenko, V. Y.
    Ionova, T. I.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S422 - S422
  • [2] QUALITY OF LIFE AND SYMPTOM PROFILE IN LYMPHOMA PATIENTS IN COMPLETE REMISSION AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Fedorenko, D.
    Melnichenko, V.
    Mochkin, N.
    Kurbatova, K.
    Ionova, T.
    HAEMATOLOGICA, 2015, 100 : 147 - 147
  • [3] CLINICAL AND SYMPTOM PROFILE IN MULTIPLE SCLEROSIS PATIENTS AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Novik, A.
    Kuznetsov, A.
    Ionova, T.
    Melnichenko, V.
    Fedorenko, D.
    Mochkin, N.
    Kartashov, A.
    Kurbatova, K.
    Gorodokin, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 273 - 273
  • [4] AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) CAN BE A SUCCESSFUL THERAPY FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
    Kopinska, A.
    Krawczyk-Kulis, M.
    Helbig, G.
    Grygoruk-Wisniowska, I.
    Kyrcz-Krzemien, S.
    HAEMATOLOGICA, 2014, 99 : 726 - 727
  • [5] SYMPTOM PROFILES IN SURVIVORS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Mitchell, S.
    Bevans, M.
    Wehrlen, L.
    Cole, M.
    Silverman, L.
    Prachenko, O.
    Koklanaris, E.
    Wallen, G.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 201 - 201
  • [6] Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients
    DA Soligo
    GLambertenghi Deliliers
    F Servida
    N Quirici
    S Campiglio
    E Tagliaferri
    A Oriani
    L Romitti
    A Della Volpe
    C Annaloro
    Bone Marrow Transplantation, 1998, 21 : 15 - 22
  • [7] Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients
    Soligo, DA
    Deliliers, GL
    Servida, F
    Quirici, N
    Campiglio, S
    Tagliaferri, E
    Oriani, A
    Romitti, L
    Della Volpe, A
    Annaloro, C
    BONE MARROW TRANSPLANTATION, 1998, 21 (01) : 15 - 22
  • [8] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [9] Autologous haematopoietic stem cell transplantation for lymphoma: experience in Shiraz
    Ramzi, M.
    Nourani, H.
    Zakerinia, M.
    Dehghani, M.
    Vojdani, R.
    Haghighinejad, H.
    Haghshenas, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S453 - S453
  • [10] Atrial Fibrillation After Autologous Hematopoietic Stem Cell Transplantation (AHSCT)
    Orozco Araujo, Silvana
    Ochoa Montes, Andrea
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S278 - S278